Skip to main content
OpenTrials
Completed

NCT Number: NCT01879774

Characterisation of Neuropsychological and Motoric Performance in Patients With Hyponatremia

The aim of this epidemiological study is to characterize the neuropsychological and motoric performance in patients with hyponatremia. Newer studies revealed an association between mild hyponatremia and unstable walking, frequency of falls and risk of a fracture, questioning the paradigm of an "asymptomatic" hyponatremia. Until now, there is no known detailed investigation and characterisation of the cognitive and motoric performance or limitation by this disorder. Therefore this study will investigate patients with hyponatremia on the basis of neuropsychological and neurological tests.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Cologne, Cologne, Germany

Loading trial locations.

About this study

Hyponatremia is the most common electrolyte disorder in outpatients and hospitalized patients. The prevalence of hospital-associated hyponatremia is estimated to be up to 40%. Especially mild to moderate hyponatremia (125-136 mmo/l) without apparent symptoms has seldomly been accurately assessed but rather seen as clinically irrelevant. Cognitive limitations, unstable gait and motoric disorders as well as depressive conditions were described in smaller studies and single case reports.

In terms of the question, if a therapeutic influence is also reasonable in slight symptomatic hyponatremia it is necessary to establish an accurate phenotyping of patients with hyponatremia, which quantifies the individual cognitive, motoric and psychological qualities.

Patients with hyponatremia will be examined on the basis of standardized neuropsychological and neurological tests. Following questions are to be answered with this study:

  • Which cognitive, motoric and psychological functions are impaired due to hyponatremia?
  • Is there a correlation between the extend of hyponatremia and the different test results?
  • Is there an intraindividual difference in test results during hyponatremia and normal sodium concentrations?

In addition to clinical testing, functional magnetic resonance imaging (fMRI) will be performed before and after therapy in up to 40 patients with hyponatremia. Functional magnetic resonance imaging (fMRI) is an imaging procedure in which local changes in cerebral oxygen concentration can be used to draw conclusions about brain activity. In connection with the current research project, an initial contribution is to be made in order to close the existing knowledge gap as to whether a functionally-image-morphologically tangible change in cerebral activity can also be depicted non-invasively by means of fMRI during hyponatremia or after its compensation. Another component of cerebral evaluation in this context is volumetry in fMRI.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Men and women 18 years of age or older
  • Hyponatremia with serum sodium < 130 mmol/l
  • Men and women with normal serum sodium > 130 mmol/l (control group)

Exclusion criteria

  • traumatic cerebral injury, hemorrhagic and ischemic insult as cause of hyponatremia
  • professional or private relationship between subject and the investigators, or dependance on the investigators
  • Placement in an institution based on official orders
  • Patients who are unable to give informed consent
  • Patients with contraindication for MRI investigation

Treatment and study plan

Neuropsychological and motoric tests

Other
  • Neuropsychological tests
  • Mini Mental Status Test
  • Dem-Tect
  • Rey-Osterrieth Complex Figure Test
  • Trailmaking Test
  • Beck Depression Inventory
  • d2-R (optional)
  • Motoric tests
  • modified UPDRS (Unified Parkinson Disease Rating Scale) Part III
  • Timed-up-and-go Test
  • Halstead Fingertapping Test
  • AIMS (Abnormal involuntary movement scale)
  • EEG (only in patients with hyponatremia)
  • MRI (only in patients with hyponatremia)

Primary outcomes

  1. Assessment of Performance in individual tests

    Time frame: Change in individual tests at Baseline and at least 48 hours after first assessment

Secondary outcomes

  1. Assessment of cerebral basal activity in fMRI during hyponatremia and after its compensation

    Time frame: Change in fMRI from baseline and at least 48 hours after first assessment

Sponsors and collaborators

Lead sponsor

University of Cologne

Other

Registry information

Important dates

Study start
2012
Primary completion
2022
Study completion
2022
First posted
Jun 18, 2013
Registry last updated
May 25, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.